Literature DB >> 21547

Role of the major histocompatibility complex in resistance to Marek's disease: restriction of the growth of JMV-MD tumor cells in genetically resistant birds.

B M Longenecker, F Pazderka, J S Gavora, J L Spencer, E A Stephens, R L Witter, R F Ruth.   

Abstract

B21 is associated with resistance to Marek's disease (MD). Forty populations of chickens from all over the world were examined for the presence of the B21 allele. B21 was found in twelve of these populations and it's presence was confirmed by GVH testing in all ten populations which were tested. The populations in which B21 was detected represent the extreme production types of the species and include the progenitor of the species, the Red Jungle Fowl. Our studies suggest that B21 may have strong survival value for the species. An allogeneic transplantable lymphoma of MD, the JMV tumor cell line, grows more slowly in MD resistant (B21/B21) chicks than in MD susceptible (B2/B2) chicks. This is the first direct evidence that genetic resistance to MD may involve an active (immunological?) restriction of tumor cell growth. JMV cells were further characterized as a transplant of B1 carrying lymphoblastoid cells, an allele which may be associated with susceptibility to MD.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21547     DOI: 10.1007/978-1-4613-4169-7_27

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease.

Authors:  Pete Kaiser; Greg Underwood; Fred Davison
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Contribution of mutation, recombination, and gene conversion to chicken MHC-B haplotype diversity.

Authors:  Kazuyoshi Hosomichi; Marcia M Miller; Ronald M Goto; Yujun Wang; Shingo Suzuki; Jerzy K Kulski; Masahide Nishibori; Hidetoshi Inoko; Kei Hanzawa; Takashi Shiina
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 3.  Structure and properties of the major histocompatibility complex of the chicken. Speculations on the advantages and evolution of polymorphism.

Authors:  B M Longenecker; T R Mosmann
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 4.  Major histocompatibility complex of chickens: genes, antigens, differential features, and special contributions to our knowledge of the advantages of polymorphism of cell surface antigens.

Authors:  B M Longenecker
Journal:  Surv Immunol Res       Date:  1982

5.  An MHC class I immune evasion gene of Marek׳s disease virus.

Authors:  Cari Hearn; Likit Preeyanon; Henry D Hunt; Ian A York
Journal:  Virology       Date:  2014-11-27       Impact factor: 3.616

6.  Histocompatibility typing by cellular radioimmunoassay.

Authors:  B M Longenecker; B Singh; M Gallatin; C Havele
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

7.  Differentially expressed genes in a flock of Chinese local-breed chickens infected with a subgroup J avian leukosis virus using suppression subtractive hybridization.

Authors:  Guiping Zhao; Maiqing Zheng; Jilan Chen; Jie Wen; Chunmei Wu; Wenjuan Li; Libo Liu; Yuan Zhang
Journal:  Genet Mol Biol       Date:  2010-03-01       Impact factor: 1.771

8.  The MHC haplotypes of the chicken.

Authors:  M Simonsen; M Crone; C Koch; K Hála
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

9.  Transcriptional profiling of mEq-dependent genes in Marek's disease resistant and susceptible inbred chicken lines.

Authors:  Sugalesini Subramaniam; Likit Preeyanon; Hans H Cheng
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

Review 10.  Brief review of the chicken Major Histocompatibility Complex: the genes, their distribution on chromosome 16, and their contributions to disease resistance.

Authors:  Marcia M Miller; Robert L Taylor
Journal:  Poult Sci       Date:  2016-01-06       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.